# Clinical Study of OncoSorb® in Patients With Advanced Cancer Entities

> **NCT01013168** · PHASE1,PHASE2 · TERMINATED · sponsor: **BioPheresis GmbH** · enrollment: 4 (actual)

## Conditions studied

- Advanced Cancer Entities

## Interventions

- **PROCEDURE:** Apheresis using the OncoSorb column

## Key facts

- **NCT ID:** NCT01013168
- **Lead sponsor:** BioPheresis GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-08
- **Primary completion:** 2010-04
- **Final completion:** 2011-02
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Achievement of feasibility and safety without achievement of clinical response.
- **Last updated:** 2011-07-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01013168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01013168, "Clinical Study of OncoSorb® in Patients With Advanced Cancer Entities". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01013168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*